NO990594D0 - Farmas°ytisk aerosolsammensetning - Google Patents

Farmas°ytisk aerosolsammensetning

Info

Publication number
NO990594D0
NO990594D0 NO990594A NO990594A NO990594D0 NO 990594 D0 NO990594 D0 NO 990594D0 NO 990594 A NO990594 A NO 990594A NO 990594 A NO990594 A NO 990594A NO 990594 D0 NO990594 D0 NO 990594D0
Authority
NO
Norway
Prior art keywords
aerosol composition
surface aerosol
pharmaceutical surface
pharmaceutical
composition
Prior art date
Application number
NO990594A
Other languages
English (en)
Other versions
NO327775B1 (no
NO990594L (no
Inventor
David Lewis
David Ganderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO990594(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO990594D0 publication Critical patent/NO990594D0/no
Publication of NO990594L publication Critical patent/NO990594L/no
Publication of NO327775B1 publication Critical patent/NO327775B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19990594A 1997-06-13 1999-02-09 Farmasoytisk aerosolsammensetning NO327775B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions
PCT/EP1998/003533 WO1998056349A1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition

Publications (3)

Publication Number Publication Date
NO990594D0 true NO990594D0 (no) 1999-02-09
NO990594L NO990594L (no) 1999-04-13
NO327775B1 NO327775B1 (no) 2009-09-21

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990594A NO327775B1 (no) 1997-06-13 1999-02-09 Farmasoytisk aerosolsammensetning

Country Status (45)

Country Link
EP (2) EP0920302B2 (no)
JP (1) JP4380802B2 (no)
KR (1) KR100546239B1 (no)
CN (1) CN1138532C (no)
AR (1) AR012977A1 (no)
AT (1) ATE222751T1 (no)
AU (1) AU729966B2 (no)
BG (1) BG63906B1 (no)
BR (1) BR9805993B1 (no)
CA (1) CA2263445C (no)
CO (1) CO4940408A1 (no)
CZ (1) CZ295521B6 (no)
DE (1) DE69807420T3 (no)
DK (1) DK0920302T4 (no)
DZ (1) DZ2516A1 (no)
EA (1) EA001259B1 (no)
EE (1) EE03664B1 (no)
ES (1) ES2182351T5 (no)
GB (1) GB2326334A (no)
GE (1) GEP20012462B (no)
HK (1) HK1022271A1 (no)
HR (1) HRP980317B1 (no)
HU (1) HU228487B1 (no)
ID (1) ID21491A (no)
IL (1) IL128484A (no)
IN (1) IN189317B (no)
IS (1) IS2435B (no)
IT (1) IT1293803B1 (no)
MA (1) MA26507A1 (no)
ME (2) MEP44008A (no)
MY (1) MY119074A (no)
NO (1) NO327775B1 (no)
NZ (1) NZ334149A (no)
PL (1) PL193721B1 (no)
PT (1) PT920302E (no)
RS (1) RS51274B (no)
SA (1) SA98190821B1 (no)
SI (1) SI0920302T2 (no)
SK (1) SK284430B6 (no)
TN (1) TNSN98087A1 (no)
TR (1) TR199900288T1 (no)
TW (1) TW555570B (no)
UA (1) UA70289C2 (no)
WO (1) WO1998056349A1 (no)
ZA (1) ZA985136B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
EP1143930B8 (en) 1999-09-11 2008-03-19 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
WO2001037805A1 (en) * 1999-11-23 2001-05-31 Glaxo Group Limited Pharmaceutical formulations of salmeterol
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
DZ3358A1 (fr) 2000-05-22 2001-11-29 Chiesi Farma Spa Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
DK1273292T3 (da) 2001-07-02 2004-10-04 Chiesi Farma Spa Optimeret tobramycinformulering til aerosoldannelse
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
JP2005523905A (ja) 2002-03-01 2005-08-11 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ ホルモテロール（ｆｏｒｍｏｔｅｒｏｌ）超微細調合物
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
ES2275778T3 (es) * 2002-06-06 2007-06-16 Chiesi Farmaceutici S.P.A. Solubilizacion de farmacos en propulsores de hfa mediante emulsiones.
EP1599184A4 (en) * 2003-02-04 2009-06-24 Chrysalis Tech Inc FULLY HALOGENATED FLUOROCARBON HYDROGEN AND HYDROFLUOROCHLOROUS HYDROGEN FUELS AND METHOD FOR THE PRODUCTION AND USE THEREOF
AU2004224367B2 (en) * 2003-03-20 2009-10-08 Boehringer Ingelheim Pharmaceuticals, Inc. Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
JP5209963B2 (ja) 2004-07-02 2013-06-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 噴霧剤としてｔｇ２２７ｅａ又はｔｇ１３４ａを含有するエアロゾル懸濁製剤
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
AU2008325290B2 (en) * 2007-11-07 2011-12-08 Astrazeneca Ab Dry powder formulations comprising ascorbic acid derivates
KR101798691B1 (ko) * 2010-09-06 2017-11-16 키에시 파르마슈티시 엣스. 피. 에이. 계량된-투여량 흡입기 및 계량된-투여량 흡입기의 사용 방법
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
MA43782A (fr) 2016-03-31 2021-04-28 Chiesi Farm Spa Dispositif d'inhalation d'aérosol
EP3607951A1 (en) * 2016-09-19 2020-02-12 Mexichem Fluor S.A. de C.V. Pharmaceutical composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2573275B2 (ja) † 1986-03-10 1997-01-22 ブルグハルト，クルト 薬学的製剤及びその製造法
CA1293929C (en) † 1986-03-10 1992-01-07 Kurt Burghart Pharmaceutical composition containing nifedipine
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
CA2094266C (en) † 1990-10-18 1999-06-01 Robert K. Schultz Aerosol formulations of beclomethasone-17,21-dipropionate
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP0653205B1 (en) † 1991-06-10 2002-10-16 Schering Corporation Non-chloroflurocarbon aerosol formulations
HUT67449A (en) † 1991-06-10 1995-04-28 Schering Corp Aerosol formulations containing 1,1,1,2,3,3,3-heptafluoropropane
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DK0616525T3 (da) * 1991-12-12 1996-01-08 Glaxo Group Ltd Medikamenter
DE69218455T2 (de) * 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
EP0673240B1 (en) * 1992-12-09 1999-03-24 Boehringer Ingelheim Pharmaceuticals Inc. Stabilized medicinal aerosol solution formulations
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
AU700162B2 (en) † 1994-05-13 1998-12-24 Aradigm Corporation Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
CA2273835A1 (en) † 1996-12-04 1998-06-11 Bioglan Ireland (R & D) Limited Pharmaceutical compositions and devices for their administration
WO1998034595A1 (de) † 1997-02-05 1998-08-13 Jago Research Ag Medizinische aerosolformulierungen

Also Published As

Publication number Publication date
BR9805993B1 (pt) 2009-05-05
CA2263445A1 (en) 1998-12-17
ME00333B (me) 2011-02-10
HUP0001339A3 (en) 2000-10-30
DZ2516A1 (fr) 2004-11-08
DE69807420D1 (de) 2002-10-02
JP4380802B2 (ja) 2009-12-09
YU6999A (sh) 2000-03-21
AR012977A1 (es) 2000-11-22
KR100546239B1 (ko) 2006-01-26
ES2182351T3 (es) 2003-03-01
CN1138532C (zh) 2004-02-18
MY119074A (en) 2005-03-31
EP0920302A1 (en) 1999-06-09
HRP980317A2 (en) 1999-04-30
GB2326334A (en) 1998-12-23
ZA985136B (en) 1999-01-07
GEP20012462B (en) 2001-06-25
IL128484A (en) 2004-09-27
EE03664B1 (et) 2002-04-15
DE69807420T2 (de) 2003-05-08
TR199900288T1 (xx) 1999-09-21
EA001259B1 (ru) 2000-12-25
PL193721B1 (pl) 2007-03-30
SK17699A3 (en) 1999-07-12
BG103221A (en) 1999-09-30
JP2000516965A (ja) 2000-12-19
TNSN98087A1 (fr) 2005-03-15
IN189317B (no) 2003-02-08
ID21491A (id) 1999-06-17
BR9805993A (pt) 1999-08-31
ITMI971798A1 (it) 1999-01-28
RS51274B (sr) 2010-12-31
DK0920302T3 (da) 2002-12-23
KR20000068171A (ko) 2000-11-25
CN1229355A (zh) 1999-09-22
UA70289C2 (uk) 2004-10-15
IL128484A0 (en) 2000-01-31
EE9900055A (et) 1999-08-16
CA2263445C (en) 2008-09-09
PT920302E (pt) 2002-11-29
SA98190821B1 (ar) 2006-11-19
DK0920302T4 (da) 2006-10-09
EP1219293A3 (en) 2003-05-28
CZ46299A3 (cs) 1999-07-14
HK1022271A1 (en) 2000-08-04
IS4974A (is) 1999-02-11
MA26507A1 (fr) 2004-12-20
BG63906B1 (bg) 2003-06-30
EP0920302B2 (en) 2006-06-21
SI0920302T2 (sl) 2006-10-31
AU8626298A (en) 1998-12-30
NO327775B1 (no) 2009-09-21
NZ334149A (en) 2000-07-28
AU729966B2 (en) 2001-02-15
HU228487B1 (en) 2013-03-28
EP1219293A2 (en) 2002-07-03
CO4940408A1 (es) 2000-07-24
DE69807420T3 (de) 2006-11-16
CZ295521B6 (cs) 2005-08-17
PL331531A1 (en) 1999-07-19
HRP980317B1 (en) 2002-06-30
HUP0001339A2 (hu) 2000-09-28
IS2435B (is) 2008-10-15
NO990594L (no) 1999-04-13
SI0920302T1 (en) 2002-12-31
ATE222751T1 (de) 2002-09-15
ES2182351T5 (es) 2007-03-16
SK284430B6 (sk) 2005-04-01
EA199900201A1 (ru) 1999-06-24
MEP44008A (en) 2011-02-10
WO1998056349A1 (en) 1998-12-17
TW555570B (en) 2003-10-01
GB9712434D0 (en) 1997-08-13
IT1293803B1 (it) 1999-03-10
EP0920302B1 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
NO990594D0 (no) Farmas°ytisk aerosolsammensetning
DK1073417T3 (da) Farmaceutisk aerosolformulering
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
ID24654A (id) Formulasi farmasi omeprazola
ID27415A (id) Komposisi farmaseutik
NO985539D0 (no) Farmas°ytiske blandinger
ID29262A (id) Komposisi farmasi
ID27201A (id) Komposisi farmasi
DE69936202D1 (de) Aerosol-zerstäuber
ID27150A (id) Sediaan levotiroksin bahan farmasi
DE60035436D1 (de) Aerosolzusammensetzung
EE9900545A (et) Farmatseutiline kompositsioon
ID29294A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
ID26215A (id) Komposisi farmasi
ID23531A (id) Komposisi farmasi
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
BR1100755A (pt) composição farmacêutica
PT1041984E (pt) Composicao farmaceutica bebivel
BR1101151A (pt) Compostos e composição farmacêutica

Legal Events

Date Code Title Description
MK1K Patent expired